Current treatment status-Did not start treatment yet - Page 27 of 37 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Non-small cell lung cancer – no survival benefit between two types of surgery

Posted by on Apr 7, 2015 in Lung cancer | 0 comments

In a nutshell This study compared the long-term outcome for non-small cell lung cancer patients who underwent video-assisted surgery and those who underwent open lung surgery. Some background Video-assisted thoracoscopic surgery (VATS) involves making cuts in the chest wall and placing a scope specifically designed to view the lungs through...

Read More

Delayed chemotherapy for stage II colon cancer patients: what are the risks?

Delayed chemotherapy for stage II colon cancer patients: what are the risks?

Posted by on Apr 6, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether delayed chemotherapy treatment can affect stage II colon cancer patient survival. Some background Stage II colon cancer indicates that the cancer has invaded the outer layers of the colon, but it has not spread to the lymph nodes or to distant organs. Current treatment guidelines suggest that patients...

Read More

Over 70? Bevacizumab plus double chemotherapy treatment is safe and effective

Over 70? Bevacizumab plus double chemotherapy treatment is safe and effective

Posted by on Apr 6, 2015 in Colorectal cancer | 0 comments

In a nutshell This study examined the efficacy and safety of a combination of three drugs for treating elderly patients with metastatic colorectal cancer (cancer that has spread from the colon or rectum to distant sites).  Some background The combination of chemotherapy drugs capecitabine (Xeloda) and oxaliplatin (Eloxatin; XELOX) is safe and...

Read More

Can peritoneal spread be prevented in high risk colon cancer patients?

Can peritoneal spread be prevented in high risk colon cancer patients?

Posted by on Mar 30, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared two treatment approaches on the long-term outcomes of colon cancer patients at risk of peritoneal metastases (spread of the cancer to the lining of the abdomen). Some background The spread of colon cancer to the peritoneum is a life-threatening condition. One treatment is cytoreductive surgery with hyperthermic...

Read More

SOX or CapeOX: comparing two chemotherapy regimens for the treatment of metastatic colorectal cancer

SOX or CapeOX: comparing two chemotherapy regimens for the treatment of metastatic colorectal cancer

Posted by on Mar 23, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared disease progression and overall survival of metastatic colorectal cancer patients who underwent two different chemotherapy regimens.  Some background Metastatic colorectal cancer indicates that the cancer has spread from its original site in the bowel to distant tissues or organs. The most commonly prescribed...

Read More

High precision radiation therapy; is it warranted in high-risk prostate cancer?

High precision radiation therapy; is it warranted in high-risk prostate cancer?

Posted by on Mar 16, 2015 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the benefit associated with use of intensity-modulated radiation therapy (IMRT), a form of high precision radiation therapy. Some background IMRT is a novel radiation therapy option for patients with prostate cancer that has not yet spread (localized). IMRT may offer lower rates of treatment-related...

Read More

Is biweekly treatment with cetuximab safe and effective for patients with metastatic colorectal cancer?

Is biweekly treatment with cetuximab safe and effective for patients with metastatic colorectal cancer?

Posted by on Mar 16, 2015 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the efficacy and safety of administering biweekly (every 14 days) cetuximab (Erbitux) plus standard chemotherapy to patients with metastatic colorectal cancer (cancer that has spread to other organs). Some background Cetuximab is a drug that binds to the epidermal growth factor receptor (EGFR) protein. As EGRF is...

Read More

How is sexual functioning affected after radiotherapy in prostate cancer?

How is sexual functioning affected after radiotherapy in prostate cancer?

Posted by on Mar 2, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effects of sildenafil citrate in improving sexual function after radiotherapy. Some background Radiotherapy is the use of high-energy rays to target and cure cancer with minimal damage to normal cells and is a common treatment option in prostate cancer. It can be given from outside the body or from...

Read More